近期许多研究者们在高水平的SCI期刊上发表了关于我公司产品的研究成果。这充分证明了我们公司产品质量可靠、性能卓越，并且具有广泛的应用价值。同时，我们也一直致力于提供优质的售后服务，为用户提供及时、专业、周到的技术支持。我们相信，通过持续不断地改进和升级，我们的产品会继续得到众多科研人员的认可和信赖。

siRNA产品

期刊：Cell 影响因?: 66.85 (1区Q1)

?期：2022-10-04

DOI ：10.1016/j.cell.2022.09.001

Methods

siRNAs oligos were purchased from JTS Scientific

Signal Transduction and Targeted Therapy (2022) 7:400 ;

https://doi.org/10.1038/s41392-022-01239-w

期刊：Signal Transduction and Targeted Therapy 影响因?: 38.104 (1区Q1)

?期：2022-12-27

DOI ：10.1038/s41392-022-01239-w

Methods

RNA interference CDK2 specific siRNA was purchased from JTSBIO Co., Ltd (Wuhan,China), with target sequences,

#1    5’CCAUCAAGCUAGCAGACUUTT3’,

#2 5’CCAGCUCUUCCGGAUCUUUTT-3’,

#3 5’-CCUCCA CCGAGACCUUAAATT-3’.

Control siRNA target sequence 5’-UU CUCCGAACGUGUCACGUTT-3’.

期刊：Nature communications 影响因?: 17.694 (1区Q1)

?期：2022-01-10

DOI ：10.1038/s41467-021-27670-1

Methods

siRNAs targeting STING and SEC23A were purchased from JTSBIO.

期刊：Signal transduction and targeted therapy 影响因?: 39.3 (1区Q1)

?期：2022-02-25

DOI ：10.1038/s41392-022-00873-8

Methods

RNA interference Small interfering RNA (siRNA) oligos targeting MMP13, YEATS2,HOXC10 or NECAB2 were provided by JTSBIO (Supplementary Table S4). The transfection of each siRNA was performed with Lipofectamine 3000 (Invitrogen). The specific sequences for target genes are provided in the supplementary information

期刊：Cancer letters 影响因?: 9.756

?期：2023-03-04

DOI ：10.1016/j.canlet.2023.216118

Methods

Both the scramble siRNA control and siRNA targeting human LINC00663 were synthesized by JTSBIO Co., Ltd

高分文献有奖征集

要求：使用我司产品并带有我司正式名称JTSBIO Co.,Ltd(Wuhan,China)，分值≥5；

奖励：每分100元，上不封顶